Shandong Lukang PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 4/6
Shandong Lukang PharmaceuticalLtd has a total shareholder equity of CN¥3.8B and total debt of CN¥2.8B, which brings its debt-to-equity ratio to 74.2%. Its total assets and total liabilities are CN¥8.9B and CN¥5.1B respectively. Shandong Lukang PharmaceuticalLtd's EBIT is CN¥262.7M making its interest coverage ratio 3.8. It has cash and short-term investments of CN¥900.4M.
Key information
74.2%
Debt to equity ratio
CN¥2.83b
Debt
Interest coverage ratio | 3.8x |
Cash | CN¥900.41m |
Equity | CN¥3.81b |
Total liabilities | CN¥5.10b |
Total assets | CN¥8.91b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 600789's short term assets (CN¥3.7B) exceed its short term liabilities (CN¥3.5B).
Long Term Liabilities: 600789's short term assets (CN¥3.7B) exceed its long term liabilities (CN¥1.6B).
Debt to Equity History and Analysis
Debt Level: 600789's net debt to equity ratio (50.5%) is considered high.
Reducing Debt: 600789's debt to equity ratio has increased from 50.9% to 74.2% over the past 5 years.
Debt Coverage: 600789's debt is well covered by operating cash flow (22.5%).
Interest Coverage: 600789's interest payments on its debt are well covered by EBIT (3.8x coverage).